The purpose of this study is to determine if buprenorphine or methadone is better for the treatment of chronic pain among patients who have become addicted to prescription narcotics.
The purpose of this randomized clinical trial is to compare methadone with buprenorphine for the treatment of chronic pain among patients who have developed a physical dependence on prescription opiate analgesics that is associated with psychosocial dysfunction (i.e., addiction).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
54
Oral, 10-60 mg per day, 2-4 times per day, 6 months
Sub-lingual, 4-16 mg per day, divided 2-4 times/day, 6 months
Sheehan Memorial Hospital
Buffalo, New York, United States
Erie County Medical Center
Buffalo, New York, United States
Number of Participants Retained in Treatment
This outcome assesses the number of participants who completed the treatment after 6 months.
Time frame: 6 months
Numerical Rating Score for Pain
Pain was measured using a 0-10 point numerical rating scale (NRS) with 0 representing no pain and 10 representing worst pain possible.
Time frame: 6 months
Numerical Rating Score for Functioning
We assessed functioning measured on a 0-10 point numerical rating scale (NRS)with 0 being the least amount of functioning and 10 the best amount of functioning.
Time frame: 6 months
Self-reported Illicit Opioid Use
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.